:

Hyun Jin Park1,2, Minoh Ko1, In-Wha Kim1

  • 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul08826, Republic of Korea.

PubMed
概括

对于个性化癌症治疗来说,确定高素诱导过敏反应 (HSR) 的危险因素至关重要. 过敏史可能会增加HSR风险,但其他因素显示出显著的异质性,需要个性化患者护理.